| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―May―16 |
Could Acute COVID-19 Infection Ignite Thrombotic Risk? |
Joshua M Stolker, Philippe G Steg, Roberta Rossini, Dorairaj Prabhakaran, Lale Tokgözoğlu, Naveed Sattar |
| 2 |
[GO] |
2024―Aug―09 |
Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice |
Andrea Di Lenarda, Nicola Ferri, Massimiliano Lanzafame, Eva Agostina Montuori, Luciano Pacelli |
| 3 |
[GO] |
2024―Jul―27 |
The Impact on Efficacy and Safety of Patients Receiving Oral Anticoagulant Medication (Warfarin) during the COVID-19 Pandemic |
Ubonwan Sapoo, Nuengruthai Phunpha, Patipan Pusopa, Bancha Sookananchai, Chanthaporn Imbumroong, Nilobol Chuemsanthia, Kitiya Muangyot |
| 4 |
[GO] |
2023―Oct―19 |
Cardiac Involvement Due to COVID-19: Insights from Imaging and Histopathology |
Valentina O Puntmann, Anastasia Shchendrygina, Carlos Rodriguez Bolanos, Mame Madjiguène Ka, Silvia Valbuena, Andreas Rolf, et al. (+2) Felicitas Escher, Eike Nagel |
| 5 |
[GO] |
2023―Sep―14 |
Cardiovascular Disease and COVID-19 Vaccines: A Systematic Review and Analysis of Published Cases |
Abdulrhman Khaity, Ala’ Abdala Mohamad Rababah, Omar A Abdelwahab, Khaled Albakri, Rehab Adel Diab, Nada Mostafa Al-dardery, et al. (+4) Mahmoud Abbassy, Balqees M Al-Hanaqtah, Ahmed K Awad, Tamam Mohamad |
| 6 |
[GO] |
2022―Feb―24 |
European Society of Cardiology Highlights: Late-breaking Trials - COVID-19 |
Maki Komiyama, Koji Hasegawa |
| 7 |
[GO] |
2021―Sep―14 |
Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases |
Maki Komiyama, Koji Hasegawa |
| 8 |
[GO] |
2021―Mar―09 |
The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019 |
Eliecer Coto, Pablo Avanzas, Juan Gómez |
| 9 |
[GO] |
2021―Mar―04 |
Coronavirus Disease 2019: Cardiac Complications and Considerations for Returning to Sports Participation |
Daniel X Augustine, Tracey Keteepe-Arachi, Aneil Malhotra |
| 10 |
[GO] |
2020―Nov―13 |
Coronavirus Disease 2019 and Cardiac Arrhythmias |
Antoni Martínez-Rubio, Soledad Ascoeta, Fadwa Taibi, Josep Guindo Soldevila |
| 11 |
[GO] |
2020―Aug―24 |
The Coronavirus Disease 2019 Outbreak Highlights the Importance of Sex-sensitive Medicine |
Angela HEM Maas, Sabine Oertelt-Prigione |
| 12 |
[GO] |
2020―Aug―13 |
Treatment of Coronavirus Disease 2019: Shooting in the Dark |
Juan Tamargo |
| 13 |
[GO] |
2020―Aug―07 |
Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness |
Maki Komiyama, Koji Hasegawa |
| 14 |
[GO] |
2020―Aug―03 |
Coronavirus Disease 2019 and Catheterisation Laboratory Considerations: “Looking for Essentials” |
Syed Haseeb Raza Naqvi, Madiha Fatima, Fady Gerges, Sara Moscatelli, Tugba Kemaloglu Oz, Irina Kotlar, et al. (+3) Nigar Babazade, Arash Hashemi, Abdallah Mostafa Almaghraby |
| 15 |
[GO] |
2020―Jul―19 |
Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019 |
Marco Rossato, Angelo Di Vincenzo |
| 16 |
[GO] |
2020―Jul―19 |
Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019 |
Maki Komiyama, Koji Hasegawa |
| 17 |
[GO] |
2020―Jun―23 |
Myocardial and Microvascular Injury Due to Coronavirus Disease 2019 |
Rocco A Montone, Giulia Iannaccone, Maria Chiara Meucci, Filippo Gurgoglione, Giampaolo Niccoli |
| 18 |
[GO] |
2020―Jun―19 |
Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management |
Mahmoud Abdelnabi, Nouran Eshak, Yehia Saleh, Abdallah Almaghraby |
| 19 |
[GO] |
2020―Jun―01 |
Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early? |
Maki Komiyama, Koji Hasegawa, Akira Matsumori |
| 20 |
[GO] |
2020―May―18 |
Ethical Issues in Decision-making Regarding the Elderly Affected by Coronavirus Disease 2019: An Expert Opinion |
David Martínez-Sellés, Helena Martínez-Sellés, Manuel Martínez-Sellés |
| 21 |
[GO] |
2020―Apr―24 |
Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic |
Maki Komiyama, Koji Hasegawa |
